{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:01:21Z","timestamp":1780718481123,"version":"3.54.1"},"reference-count":18,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.1620\/tjem.2025.j114","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T22:08:48Z","timestamp":1760566128000},"page":"11-15","source":"Crossref","is-referenced-by-count":0,"title":["Cancer Incidence Rates Between &lt;i&gt;BRCA1\/2&lt;\/i&gt; Pathogenic Variant Carriers and Non-Carriers in Real-World Clinical Practice"],"prefix":"10.1620","volume":"269","author":[{"given":"Akiko","family":"Ebata","sequence":"first","affiliation":[{"name":"Departments of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tada","sequence":"additional","affiliation":[{"name":"Departments of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narumi","family":"Harada-Shoji","sequence":"additional","affiliation":[{"name":"Departments of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Hamanaka","sequence":"additional","affiliation":[{"name":"Departments of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine"},{"name":"Tohoku Medical Megabank Organization, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Miyashita","sequence":"additional","affiliation":[{"name":"Departments of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miku","family":"Sato","sequence":"additional","affiliation":[{"name":"Departments of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Ishida","sequence":"additional","affiliation":[{"name":"Departments of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Breast Cancer Linkage Consortium  (1999)  Cancer risks in BRCA2 mutation carriers.  <i>J. Natl. Cancer Inst.<\/i>, 91, 1310-1316. https:\/\/doi.org\/10.1093\/jnci\/91.15.1310","DOI":"10.1093\/jnci\/91.15.1310"},{"key":"2","doi-asserted-by":"publisher","unstructured":"Bryant, H.E., Schultz, N., Thomas, H.D., Parker, K.M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N.J.&amp;Helleday, T. (2005)  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.  <i>Nature<\/i>, 434, 913-917. https:\/\/doi.org\/10.1038\/nature03443","DOI":"10.1038\/nature03443"},{"key":"3","doi-asserted-by":"publisher","unstructured":"Castro, E., Goh, C., Olmos, D., Saunders, E., Leongamornlert, D., Tymrakiewicz, M., Mahmud, N., Dadaev, T., Govindasami, K., Guy, M., Sawyer, E., Wilkinson, R., Ardern-Jones, A., Ellis, S., Frost, D., et al. (2013)  Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.  <i>J. Clin. Oncol.<\/i>, 31, 1748-1757. https:\/\/doi.org\/10.1200\/JCO.2012.43.1882","DOI":"10.1200\/JCO.2012.43.1882"},{"key":"4","doi-asserted-by":"publisher","unstructured":"Couch, F.J., Shimelis, H., Hu, C., Hart, S.N., Polley, E.C., Na, J., Hallberg, E., Moore, R., Thomas, A., Lilyquist, J., Feng, B., McFarland, R., Pesaran, T., Huether, R., LaDuca, H., et al. (2017)  Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.  <i>JAMA Oncol.<\/i>, 3, 1190-1196. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0424","DOI":"10.1001\/jamaoncol.2017.0424"},{"key":"5","doi-asserted-by":"publisher","unstructured":"Dullens, B., de Putter, R., Lambertini, M., Toss, A., Han, S., Van Nieuwenhuysen, E., Van Gorp, T., Vanderstichele, A., Van Ongeval, C., Keupers, M., Prevos, R., Celis, V., Dekervel, J., Everaerts, W., Wildiers, H., et al. (2020)  Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1\/2: A Review of Secondary Prevention Guidelines.  <i>J. Oncol.<\/i>, 2020, 9873954. https:\/\/doi.org\/10.1155\/2020\/9873954","DOI":"10.1155\/2020\/9873954"},{"key":"6","doi-asserted-by":"publisher","unstructured":"Farmer, H., McCabe, N., Lord, C.J., Tutt, A.N., Johnson, D.A., Richardson, T.B., Santarosa, M., Dillon, K.J., Hickson, I., Knights, C., Martin, N.M., Jackson, S.P., Smith, G.C.&amp;Ashworth, A. (2005)  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.  <i>Nature<\/i>, 434, 917-921. https:\/\/doi.org\/10.1038\/nature03445","DOI":"10.1038\/nature03445"},{"key":"7","doi-asserted-by":"publisher","unstructured":"Hayashi, S., Kubo, M., Kaneshiro, K., Kai, M., Yamada, M., Morisaki, T., Takao, Y., Shimazaki, A., Shikada, S.&amp;Nakamura, M. (2022)  Genetic medicine is accelerating in Japan.  <i>Breast Cancer<\/i>, 29, 659-665. https:\/\/doi.org\/10.1007\/s12282-022-01342-4","DOI":"10.1007\/s12282-022-01342-4"},{"key":"8","doi-asserted-by":"publisher","unstructured":"Ichikawa, H., Wakai, T., Nagahashi, M., Shimada, Y., Hanyu, T., Kano, Y., Muneoka, Y., Ishikawa, T., Takizawa, K., Tajima, Y., Sakata, J., Kobayashi, T., Kemeyama, H., Yabusaki, H., Nakagawa, S., et al. (2018)  Pathogenic germline BRCA1\/2 mutations and familial predisposition to gastric cancer.  <i>JCO Precis. Oncol.<\/i>, 2, 1-8. https:\/\/doi.org\/10.1200\/PO.18.00097","DOI":"10.1200\/PO.18.00097"},{"key":"9","doi-asserted-by":"publisher","unstructured":"Jakubowska, A., Nej, K., Huzarski, T., Scott, R.J.&amp;Lubinski, J. (2002)  BRCA2 gene mutations in families with aggregations of breast and stomach cancers.  <i>Br. J. Cancer<\/i>, 87, 888-891. https:\/\/doi.org\/10.1038\/sj.bjc.6600562","DOI":"10.1038\/sj.bjc.6600562"},{"key":"10","doi-asserted-by":"publisher","unstructured":"Ko, J.M., Ning, L., Zhao, X.K., Chai, A.W.Y., Lei, L.C., Choi, S.S.A., Tao, L., Law, S., Kwong, A., Lee, N.P., Chan, K.T., Lo, A., Song, X., Chen, P.N., Chang, Y.L., et al. (2020)  BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese.  <i>Int. J. Cancer<\/i>, 146, 1042-1051. https:\/\/doi.org\/10.1002\/ijc.32619","DOI":"10.1002\/ijc.32619"},{"key":"11","doi-asserted-by":"publisher","unstructured":"Lee, A., Moon, B.I.&amp;Kim, T.H. (2020)  BRCA1\/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies.  <i>Ann. Lab. Med.<\/i>, 40, 114-121. https:\/\/doi.org\/10.3343\/alm.2020.40.2.114","DOI":"10.3343\/alm.2020.40.2.114"},{"key":"12","doi-asserted-by":"publisher","unstructured":"Lu, H.M., Li, S., Black, M.H., Lee, S., Hoiness, R., Wu, S., Mu, W., Huether, R., Chen, J., Sridhar, S., Tian, Y., McFarland, R., Dolinsky, J., Tippin Davis, B., Mexal, S., et al. (2019)  Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.  <i>JAMA Oncol.<\/i>, 5, 51-57. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2956","DOI":"10.1001\/jamaoncol.2018.2956"},{"key":"13","doi-asserted-by":"publisher","unstructured":"Mahdavi, M., Nassiri, M., Kooshyar, M.M., Vakili-Azghandi, M., Avan, A., Sandry, R., Pillai, S., Lam, A.K.&amp;Gopalan, V. (2019)  Hereditary breast cancer; Genetic penetrance and current status with BRCA.  <i>J. Cell. Physiol.<\/i>, 234, 5741-5750. https:\/\/doi.org\/10.1002\/jcp.27464","DOI":"10.1002\/jcp.27464"},{"key":"14","doi-asserted-by":"publisher","unstructured":"Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M., Ding, W., et al. (1994)  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.  <i>Science<\/i>, 266, 66-71. https:\/\/doi.org\/10.1126\/science.7545954","DOI":"10.1126\/science.7545954"},{"key":"15","doi-asserted-by":"publisher","unstructured":"Momozawa, Y., Sasai, R., Usui, Y., Shiraishi, K., Iwasaki, Y., Taniyama, Y., Parsons, M.T., Mizukami, K., Sekine, Y., Hirata, M., Kamatani, Y., Endo, M., Inai, C., Takata, S., Ito, H., et al. (2022)  Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.  <i>JAMA Oncol.<\/i>, 8, 871-878. https:\/\/doi.org\/10.1001\/jamaoncol.2022.0476","DOI":"10.1001\/jamaoncol.2022.0476"},{"key":"16","doi-asserted-by":"publisher","unstructured":"Tempero, M.A., Malafa, M.P., Al-Hawary, M., Behrman, S.W., Benson, A.B., Cardin, D.B., Chiorean, E.G., Chung, V., Czito, B., Del Chiaro, M., Dillhoff, M., Donahue, T.R., Dotan, E., Ferrone, C.R., Fountzilas, C., et al. (2021)  Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl.Compr. Canc.  <i>Netw.<\/i>, 19, 439-457. https:\/\/doi.org\/10.6004\/jnccn.2021.0017","DOI":"10.6004\/jnccn.2021.0017"},{"key":"17","doi-asserted-by":"publisher","unstructured":"Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C.&amp;Micklem, G. (1995)  Identification of the breast cancer susceptibility gene BRCA2.  <i>Nature<\/i>, 378, 789-792. https:\/\/doi.org\/10.1038\/378789a0","DOI":"10.1038\/378789a0"},{"key":"18","doi-asserted-by":"publisher","unstructured":"Wooster, R., Neuhausen, S.L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., et al. (1994)  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.  <i>Science<\/i>, 265, 2088-2090. https:\/\/doi.org\/10.1126\/science.8091231","DOI":"10.1126\/science.8091231"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/1\/269_2025.J114\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:21:42Z","timestamp":1780716102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/1\/269_2025.J114\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j114","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025.J114"}}